Cancer HealthCast: NCI Program Unlocks Emerging Proteomic Data to Advance Precision Medicine
Researchers say sharing molecular cancer research data can expand cancer treatment and care.
Proteomics is an emerging field in cancer care and research. The National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) aims to get to the heart of cancer by studying its molecular basis across different cancers. The group believes expanding open-source resources and other data can lead to new treatments in cancer and expand precision medicine.
Dr. Henry Rodriguez, the founding director of the Office of Cancer Clinical Proteomics Research at NCI, discusses the program and how the related International Cancer Proteogenome Consortium (ICPC) is helping researchers pull together resources necessary to innovate cancer care.
-
Dr. Henry Rodriguez Founding Director, Office of Cancer Clinical Proteomics Research NCI
-
NOAA Nears Rollout of Its Modernized National Spatial Reference System
The new GPS-enabled National Spatial Reference System will improve accuracy for federal infrastructure projects, with full adoption expected by 2027.
3m read -
Who’s in Charge of AI at Every Federal Agency
New AI memos from the Trump administration prompt federal agencies to establish chief AI officers and OMB to launch a new CAIO AI Council.
7m read -
Navy Installations Shift to Continuous Cybersecurity Model
Shery Thomas details how Navy Installations Command is aligning with the service’s continuous cybersecurity strategy.
14m watch -
New NPS Challenge Aims to Rewrite How the Military Builds Missiles
Officials say focusing on design methods, not hardware, could unlock fast, low‑cost manufacturing for future munitions.
11m watch
